Keros Therapeutics, Inc. (KROS) revenue

Revenue · fiscal 2025
$244.06M

Keros Therapeutics, Inc. (KROS) reported revenue of $244.06M in fiscal 2025 (the year ended December 31, 2025). That is 6775.0% higher than the $3.55M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$244.06M
Change on fiscal 2024
+6775.0%
Highest on record
$244.06Mfiscal 2025
Lowest on record
$151.00Kfiscal 2023
Fiscal years on record
52019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Keros Therapeutics, Inc. revenue, in more detail

Across the 5 fiscal years on record (2019–2025), the highest was $244.06M in fiscal 2025 and the lowest $151.00K in fiscal 2023.

History · 5 fiscal years

Revenue by fiscal year

Keros Therapeutics, Inc. revenue, year by year

Keros Therapeutics, Inc. (KROS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$244.06M 6,775.0% up
2024$3.55M 2,251.0% up
2023$151.00K—
2021$20.10M—
2019$10.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on KROS

Keros Therapeutics, Inc., figure by figure

Keros Therapeutics, Inc. (KROS) overview: price, valuation and scorecard

Keros Therapeutics, Inc. revenue: questions and answers

What is Keros Therapeutics, Inc.'s revenue?

Keros Therapeutics, Inc. (KROS) reported revenue of $244.06M in fiscal 2025 (the year ended December 31, 2025). That is 6775.0% higher than the $3.55M of fiscal 2024.

What are the highest and lowest revenue figures on record for Keros Therapeutics, Inc.?

Across the 5 fiscal years on record (2019–2025), the highest was $244.06M in fiscal 2025 and the lowest $151.00K in fiscal 2023.

How is Keros Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Keros Therapeutics, Inc. it is on record here for 5 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/KROS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.